AI, Drug Development and Patient Safety
Stop Panicking About Skynet. The Real AI Risk is Already Here
In medicine, our approach to risk is a carefully honed discipline. We wouldn’t divert the bulk of our resources, our brightest minds, and our public health messaging to combat a hypothetical, world-ending superbug prophesied to emerge in fifty years, while ignoring the clear and present dangers of hospital-acquired infections, antibiotic resistance, and…
Keep reading with a 7-day free trial
Subscribe to Drug Development Executive to keep reading this post and get 7 days of free access to the full post archives.